A limb-girdle muscular dystrophy 2I model of muscular dystrophy identifies corrective drug compounds for dystroglycanopathies.

Serafini PR, Feyder MJ, Hightower RM, Garcia-Perez D, Vieira NM, Lek A, Gibbs DE, Moukha-Chafiq O, Augelli-Szafran CE, Kawahara G, Widrick JJ, Kunkel LM, Alexander MS

Open source

DOI: 10.1172/jci.insight.120493
Published: 2018 Sep 20
Container: JCI insight
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1172/jci.insight.120493,
  title = {A limb-girdle muscular dystrophy 2I model of muscular dystrophy identifies corrective drug compounds for dystroglycanopathies.},
  author = {Serafini PR and Feyder MJ and Hightower RM and Garcia-Perez D and Vieira NM and Lek A and Gibbs DE and Moukha-Chafiq O and Augelli-Szafran CE and Kawahara G and Widrick JJ and Kunkel LM and Alexander MS},
  year = {2018},
  journal = {JCI insight},
  doi = {10.1172/jci.insight.120493},
  url = {https://doi.org/10.1172/jci.insight.120493}
}

RIS

TY  - JOUR
TI  - A limb-girdle muscular dystrophy 2I model of muscular dystrophy identifies corrective drug compounds for dystroglycanopathies.
AU  - Serafini PR
AU  - Feyder MJ
AU  - Hightower RM
AU  - Garcia-Perez D
AU  - Vieira NM
AU  - Lek A
AU  - Gibbs DE
AU  - Moukha-Chafiq O
AU  - Augelli-Szafran CE
AU  - Kawahara G
AU  - Widrick JJ
AU  - Kunkel LM
AU  - Alexander MS
PY  - 2018
JO  - JCI insight
DO  - 10.1172/jci.insight.120493
UR  - https://doi.org/10.1172/jci.insight.120493
ER  -

APA

PR, S., MJ, F., RM, H., D, G., NM, V., A, L., DE, G., O, M., CE, A., G, K., JJ, W., LM, K., & MS, A. (2018). A limb-girdle muscular dystrophy 2I model of muscular dystrophy identifies corrective drug compounds for dystroglycanopathies.. JCI insight. https://doi.org/10.1172/jci.insight.120493

Source records

pubmed · retrieved 2026-09-27T01:14:59.860Z